Patent · US Active

Cell lines

US9732367B2 · kind B2 · utility

2Cited by
4References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 24, 2013
Grant dateAug 15, 2017
Priority date
Expiry dateSep 24, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y601/01
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There is provided inter alia a process for stabilizing a eukaryotic cell line which expresses PylRS and tRNAPyl and which is suitable for incorporation of a gene encoding a target protein containing one or more non-natural amino acids encoded by a nonsense codon which comprises culturing said cell line under conditions in which the adverse effect of tRNAPyl expression on cell viability and/or cell growth is reduced or eliminated.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.